Every prescribed therapy plays a unique role in the fight against CF.
CFTR modulators were studied in patients taking Pulmozyme. CFTRs modulators are gene-specific treatments. They were studied for use in patients with specific genetic mutations (changes in specific genes). The CF patients in these studies took the CFTR modulator in addition to their prescribed CF therapies (eg, Pulmozyme, bronchodilators, and inhaled antibiotics).
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
Su navegador está configurado en español. ¿Preferirías el sitio en español?